Emmeline Ventures’s vision is simple: When more women are funded, our future becomes one of growth; opportunities no longer sit behind invisible doors. That philosophy was at the center of Emmeline Ventures’ conversation during Arizona Tech Week, where they offered a candid look at how they are reshaping venture capital through a focused lens on women’s health, long-term innovation, and ecosystem-driven investing. The discussion emphasized not only where Emmeline invests, but why redefining traditional investment frameworks matters for both health outcomes and economic growth.
Redefining What “Investing” Really Means
For Azin Radsan van Alebeek, Emmeline Ventures Co-Founder & General Partner, investing begins long before capital deployment. “I think everyone invests in themselves. You invest in your education, your friends, your family, your sport, your religion, whatever is important to you. You’re already building the same skill sets that apply to financial investing.”
She emphasized that financial investing often feels inaccessible when in reality, many people already practice decision-making, risk evaluation, and long-term thinking in other areas of life. “People think, ‘I haven’t been trained in that,’ but they already have the tools. They’ve just never been taught to translate them into financial investing.”
A Venture Firm Built for “Her”
Emmeline Ventures is intentionally structured around a long-term vision of innovation designed for women’s needs, not as a niche category, but as a broad economic and societal opportunity.“We invest in tech-enabled solutions that support ‘her’ overall health,” van Alebeek said.
At Emmeline, health extends beyond traditional healthcare categories. The firm invests in sectors where women’s needs and lived experiences have historically been overlooked, with a focus on three pillars of health: physical & mental, financial, and environmental.
“Physical, mental, and financial health are deeply interconnected. And environmental conditions affect health outcomes in ways we are still continuing to understand,” van Alebeek explained, referencing the Flint water crisis as one example of how environmental factors can shape long-term health and quality of life.
By taking a broader view of women’s health, Emmeline Ventures sees opportunity in markets that have historically been underfunded and overlooked.
Why Women’s Health Is an Economic Opportunity
A major focus for Emmeline Ventures is addressing long-standing gaps in women’s health research and innovation. “We are looking at problems that have been under-researched, overlooked, and underfunded for a long time,” van Alebeek said. She pointed to endometriosis as a striking example. “It affects about 10% of women, and yet it takes seven to ten years to get a diagnosis. That’s seven to ten years of intense, ongoing pain while navigating the healthcare system,” van Alebeek said.
Beyond health impacts, she emphasized the broader economic consequences.“This is not just a healthcare issue; it’s an economic issue. Productivity is reduced, caregiving capacity is reduced, and the ripple effects extend far beyond the individual.” She added that this market inefficiency is part of what makes the space compelling from an investment perspective. “There is economic opportunity here because there has been underinvestment. And that is beginning to change.”
Arizona Tech Week’s Impact and a Growing Ecosystem
For Emmeline Ventures, participating in Arizona Tech Week reinforced the strength of the Phoenix innovation ecosystem. “It was so fulfilling to my heart and soul to be part of the inaugural week. There is so much pride in this region — people are smart, kind, supportive, and mission-aligned,” van Alebeek said.
She also highlighted the value of Arizona’s collaborative environment, particularly compared to larger coastal hubs. “You can have both innovation and retreat here. It allows for deeper connection and better thinking,” she said.
Looking Ahead
When asked about the future of Emmeline Ventures, the answer ultimately came back to impact — and execution. “I’m most looking forward to our first exit. At the end of the day, venture is about building the future — and returning value when that future arrives,” van Alebeek said.
About Emmeline Ventures
Emmeline Ventures invests in solutions that help women manage their health, build their wealth, and live in a cleaner, safer world. The firm targets overlooked, high-upside markets, backing companies at the intersection of essential innovation and large-scale demand. Leveraging deep operational experience, the Emmeline team partners closely with founders to reduce early-stage risk and accelerate growth toward institutional scale. With a focused, thesis-driven strategy, Emmeline Ventures invests in high-conviction opportunities that deliver both strong financial returns and meaningful real-world impact. Learn more at emmelineventures.vc.
About the Phoenix Bioscience Core
The Phoenix Bioscience Core (PBC) is a 30-acre life sciences innovation district located in downtown Phoenix. It hosts Arizona’s three public research universities—Arizona State University, Northern Arizona University, and the University of Arizona—as well as leading genomics pioneers like the Translational Genomics Research Institute (TGen), part of the City of Hope, and the International Genomics Consortium. The PBC also collaborates with major healthcare systems, including Banner Health, Phoenix Children’s Hospital, Dignity Health, HonorHealth, Phoenix VA, and Valleywise Health, alongside a growing number of emerging life science companies. This unique concentration of research scientists and healthcare professionals fosters unprecedented collaborations, advancing precision medicine from discovery to delivery. To learn more, please visit phoenixbiosciencecore.com
By: Madisson Simental | May 20, 2026